Exchange Traded Concepts, LLC Neurocrine Biosciences Inc Transaction History

Exchange Traded Concepts, LLC

  • $10.4 Billion
  • Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 1,794 shares of NBIX stock, worth $259,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,794
Previous 7,163 74.95%
Holding current value
$259,878
Previous $900,000 72.11%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025
SELL
$123.98 - $146.67 $665,648 - $787,471
-5,369 Reduced 74.95%
1,794 $251,000
Q2 2025

Jul 10, 2025
BUY
$87.54 - $128.18 $11,905 - $17,432
136 Added 1.94%
7,163 $900,000
Q1 2025

Apr 17, 2025
SELL
$107.22 - $153.29 $118,585 - $169,538
-1,106 Reduced 13.6%
7,027 $777,000
Q4 2024

Jan 21, 2025
BUY
$111.62 - $139.44 $18,863 - $23,565
169 Added 2.12%
8,133 $1.11 Million
Q3 2024

Oct 10, 2024
BUY
$114.58 - $153.15 $206,587 - $276,129
1,803 Added 29.26%
7,964 $916,000
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $56,138 - $61,428
429 Added 7.48%
6,161 $848,000
Q1 2024

Apr 15, 2024
SELL
$130.4 - $143.74 $192,861 - $212,591
-1,479 Reduced 20.51%
5,732 $790,000
Q4 2023

Jan 05, 2024
BUY
$106.07 - $132.76 $2,757 - $3,451
26 Added 0.36%
7,211 $950,000
Q3 2023

Oct 18, 2023
SELL
$94.02 - $117.1 $4,983 - $6,206
-53 Reduced 0.73%
7,185 $808,000
Q2 2023

Jul 20, 2023
SELL
$89.53 - $104.87 $19,875 - $23,281
-222 Reduced 2.98%
7,238 $682,000
Q1 2023

Apr 12, 2023
SELL
$94.11 - $123.02 $113,873 - $148,854
-1,210 Reduced 13.96%
7,460 $755,000
Q4 2022

Jan 17, 2023
BUY
$106.72 - $127.06 $15,687 - $18,677
147 Added 1.72%
8,670 $1.04 Million
Q3 2022

Oct 07, 2022
SELL
$92.03 - $107.81 $39,480 - $46,250
-429 Reduced 4.79%
8,523 $905,000
Q2 2022

Jul 20, 2022
BUY
$75.79 - $100.07 $41,836 - $55,238
552 Added 6.57%
8,952 $873,000
Q1 2022

Apr 26, 2022
SELL
$72.45 - $94.81 $208,656 - $273,052
-2,880 Reduced 25.53%
8,400 $788,000
Q4 2021

Jan 13, 2022
BUY
$79.65 - $106.22 $408,604 - $544,908
5,130 Added 83.41%
11,280 $961,000
Q3 2021

Oct 18, 2021
BUY
$86.18 - $99.03 $483,469 - $555,558
5,610 Added 1038.89%
6,150 $590,000
Q2 2021

Jul 30, 2021
SELL
$89.43 - $102.27 $20,479 - $23,419
-229 Reduced 29.78%
540 $53,000
Q1 2021

Apr 20, 2021
SELL
$87.57 - $119.4 $27,672 - $37,730
-316 Reduced 29.12%
769 $75,000
Q4 2020

Jan 19, 2021
BUY
$86.91 - $108.33 $94,297 - $117,538
1,085 New
1,085 $104,000
Q2 2020

Jul 15, 2020
SELL
$85.09 - $130.36 $2,467 - $3,780
-29 Closed
0 $0
Q1 2020

Apr 14, 2020
BUY
$75.11 - $113.76 $2,178 - $3,299
29 New
29 $3,000

Others Institutions Holding NBIX

# of Institutions
726
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email